Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Reiner, Elsässer"'
Publikováno v:
Archives of Drug Information. 4:33-41
Introduction. Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo in a randomised, double-blind clinical trial in adu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e7db418e3506f39e58e3fbc2c0f0215
https://doi.org/10.1111/j.1753-5174.2011.00035.x
https://doi.org/10.1111/j.1753-5174.2011.00035.x
Publikováno v:
Archives of Drug Information. 3:45-53
INTRODUCTION: Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo and Epoetin beta in a randomised, double-blind clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c2b1601385d54c3b2d38a740b1cd6ac
https://doi.org/10.1111/j.1753-5174.2010.00030.x
https://doi.org/10.1111/j.1753-5174.2010.00030.x
Autor:
Oleg Gladkov, Igor Bondarenko, Anton Buchner, Udo Müller, Constantin Volovat, Reiner Elsässer, Peter Bias
Publikováno v:
SpringerPlus
Purpose The aim of this study was to demonstrate lipegfilgrastim superiority versus placebo in adults with non-small cell lung cancer receiving myelosuppressive chemotherapy. Methods This phase III, double-blind study randomized chemotherapy-naive pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9712aeec3c9889d84c4e86261a90d8f
http://europepmc.org/articles/PMC4489970
http://europepmc.org/articles/PMC4489970
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 24(1)
Lipegfilgrastim is a once-per-cycle glycoPEGylated granulocyte colony-stimulating factor (G-CSF). Noninferiority of lipegfilgrastim versus pegfilgrastim was demonstrated in a phase III trial in chemotherapy (CTx)-naive breast cancer patients. Seconda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a345dcae52542251fb68dde90d58ae5a
https://pubmed.ncbi.nlm.nih.gov/26092233
https://pubmed.ncbi.nlm.nih.gov/26092233
Publikováno v:
Breast Cancer Research and Treatment
This dose-ranging study was conducted to identify the optimal fixed dose of lipegfilgrastim compared with pegfilgrastim 6.0 mg for the provision of neutrophil support during myelosuppressive chemotherapy in patients with breast cancer. A phase 2 stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d68a9dba71ef87e953bbdcd9d861c2f
https://pubmed.ncbi.nlm.nih.gov/25261291
https://pubmed.ncbi.nlm.nih.gov/25261291
Autor:
Sergei A, Tjulandin, Peter, Bias, Reiner, Elsässer, Beate, Gertz, Erich, Kohler, Anton, Buchner
Publikováno v:
Archives of Drug Information
INTRODUCTION: Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo in a randomised, double-blind clinical trial in adu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4be5059fe9bb6d55eeeda0b75c97a1be
https://pubmed.ncbi.nlm.nih.gov/22022341
https://pubmed.ncbi.nlm.nih.gov/22022341
Autor:
Sergei A, Tjulandin, Peter, Bias, Reiner, Elsässer, Beate, Gertz, Erich, Kohler, Anton, Buchner
Publikováno v:
Archives of Drug Information
Introduction Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo and Epoetin beta in a randomised, double-blind clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a6aa88b1a38f3d080a1a4f9652b4388
https://pubmed.ncbi.nlm.nih.gov/21331363
https://pubmed.ncbi.nlm.nih.gov/21331363